glp-1 analog drugs of GLP-1RAs approved for the treatment of type 2 diabetes. FDA US Food Evolution of GLP‐1 Receptor Agonists

Setting accurate expectations is the difference between a patient who follows through and one who abandons a protocol at week 4 because they expected results at week 2

The GIP receptor activation adds another layer

The search terms used were obesity, OSA, ASP, EDS, CPAP, glucagon-like peptide-1 (GLP-1), GLP-1 receptor (GLP-1R) agonists, liraglutide (LIRA), exenatide (EXE), semaglutide (SEMA), dulaglutide (DULA), sodium-glucose co-transporters 2 (SGLT2) inhibitors, empagliflozin (EMPA), dapagliflozin (DAPA), ertugliflozin (ERTU), canagliflozin (CANA), and luseogliflozin (LUSEO)

T.et al (2023)

Luego se puede administrar una inyeccin de 1000mcg una vez al mes